DJIA 18,070.40 46.34 0.26%
NASDAQ 5,016.93 11.54 0.23%
S&P 500 2,114.49 6.20 0.29%
market minute promo

GlaxoSmithKline (NYSE: GSK)



company name or ticker
Company Photos
(Click to zoom)

GlaxoSmithKline (GSK) Upgraded From Hold to Buy

5 Stocks With Jaw-Dropping Growth Potential

These five small-cap growth stocks could soar in 2015. Here's why.

A Quick Review Of The Asthma Market

How China's Internet Censorship Affects Foreign Business

Pharmacyclics (PCYC) Jumps 16.9% on Takeover Rumors - Analyst Blog

Can Isis Pharmaceuticals (ISIS) Beat Earnings this Season? - Analyst Blog

Novartis Gets FTC Nod To Buyout Glaxo Smithkline's Cancer Drugs

2.16% Advantage For 5 Sector-Leading, Highest-Yield, Lowest-Price February Stocks

7 Sector Skipper Dividend Dogs Deliver 23% To 33% February Upsides

Celldex Therapeutics Inc. Q4 Earnings Overshadowed by FDA News

Celldex reports fourth-quarter earnings -- but the big story is an FDA decision on rindopepimut.